Your item on trial length is a good addition for the list. A related item (suggested by iwfal): “If a clinical trial wasn’t halted for futility at an interim analysis, the drug must be working!”
Also (from #msg-70370569): “If data are being presented at a medical conference, the clinical trial must be a success!”
Alas, some bio investors are destined to always remain "newbies" ;)
My name is Andy and I will always be a biotech "newbie". I got started investing in biotech at a card game eight years ago. One of my card buddies was a rep for Elan. I started doing research on biotechs and got hooked. The combination of interesting reading material and playing the odds is what got me here. I will always be handicapped by my lack of scientific background but I have a good time and have been extremely lucky, so far. This is one evil habit I am not about to give up.
News 
Market Data 
Discover 
